Mar 27, 2024 | Foods, On Demand Webinar
Reassessment of EMPs: Have You Identified the Correct Sampling Locations to Protect Your Product? An EAS Complimentary Webinar Presented by Rocelle Grabarek, EAS Independent Consultant March 27, 2024 • 1pm (Eastern) 1.5 hours Many of the environmental monitoring...
Mar 12, 2024 | FDA and USDA Regulatory Update, Foods
USDA today published its “Product of USA” final rule, which will allow voluntary “Product of USA” or “Made in the USA” label claims to be used on meat, poultry, and egg products only when they are derived from animals born, raised, slaughtered, and processed in the...
Mar 5, 2024 | Dietary Supplements, FDA and USDA Regulatory Update
The FDA recently announced final guidance for industry on “Dietary Supplements: New Dietary Ingredient Notification Procedures and Timeframes.” This guidance is intended to help manufacturers and distributors of new dietary ingredients (NDIs) and dietary supplements...
Feb 26, 2024 | Drug and Device Corner, Drugs, Medical Devices
The FDA has issued a final Guidance Document to assist drug establishment registrants with understanding the CARES Act reporting requirements. Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act guidance offers very...
Feb 19, 2024 | Cosmetics, EAS in Action, EAS in the News Cosmetics
John Bailey, an EAS consultant and the former director of FDA’s Office and Cosmetics and Colors, shared his thoughts with KFF Health News on FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late. Read...
Feb 12, 2024 | Drugs, FDA and USDA Regulatory Update
The FDA has issued a final Guidance Document to assist drug establishment registrants with understanding the CARES Act reporting requirements. Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act guidance offers very...
